Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma

Large interindividual differences in treatment outcome are observed in cancer patients undergoing chemotherapy. Our aim was to develop and validate clinical-pharmacogenetic prediction models of gemcitabine/cisplatin or pemetrexed/cisplatin treatment outcome and develop an algorithm for genotype-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Goričar, Katja, Kovač, Viljem, Dolžan, Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396189/
https://www.ncbi.nlm.nih.gov/pubmed/28422153
http://dx.doi.org/10.1038/srep46537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396189/
https://www.ncbi.nlm.nih.gov/pubmed/28422153
http://dx.doi.org/10.1038/srep46537

Ejemplares similares